Growth Metrics

Bioventus (BVS) Net Cash Flow Growth (3y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Bioventus 535.01 Mn 544.52 Mn 90.77 Mn -36.83%

Historic Data

Download Data 🔒
DateValue
Mar 28, 2026 -36.83%
Dec 31, 2025 80.12%
Sep 27, 2025 55.32%
Jun 28, 2025 30.83%
Mar 29, 2025 -5.23%
Dec 31, 2024 26.37%
Sep 28, 2024 52.24%
Jun 29, 2024 -5.44%
Mar 30, 2024 -31.28%
Dec 31, 2023 16.00%
Sep 30, 2023 26.01%
Jul 1, 2023 -90.10%
Apr 1, 2023 -26.41%